Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pRV.GFP FOXP3 Citations (2)

Originally described in: FOXP3 controls regulatory T cell function through cooperation with NFAT.
Wu Y, Borde M, Heissmeyer V, Feuerer M, Lapan AD, Stroud JC, Bates DL, Guo L, Han A, Ziegler SF, Mathis D, Benoist C, Chen L, Rao A Cell. 2006 Jul 28. 126(2):375-87.
PubMed Journal

Articles Citing pRV.GFP FOXP3

Articles
Antibody-mediated FOXP3 protein therapy induces apoptosis in cancer cells in vitro and inhibits metastasis in vivo. Heinze E, Baldwin S, Chan G, Hansen J, Song J, Clements D, Aragon R, Nishimura R, Reeves M, Weisbart R. Int J Oncol. 2009 Jul;35(1):167-73. PubMed
Tumor suppressor and T-regulatory functions of Foxp3 are mediated through separate signaling pathways. Heinze E, Chan G, Mory R, Khavari R, Alavi A, Chung SY, Nishimura RN, Weisbart RH. Oncol Lett. 2011 Jul;2(4):665-668. Epub 2011 May 13. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.